Identifying the specific structural features of metallothionein that regulate its ability to modulate astrogliosis. This project contributes directly to the Designated National Research Priority 2 and could potentially have a significant impact upon the broader Australian Community by identifying a novel and powerful therapeutic agent based upon metallothionein proteins with the ultimate aim of helping patients who have a brain injury or a neurodegenerative disease. It is important to note that ....Identifying the specific structural features of metallothionein that regulate its ability to modulate astrogliosis. This project contributes directly to the Designated National Research Priority 2 and could potentially have a significant impact upon the broader Australian Community by identifying a novel and powerful therapeutic agent based upon metallothionein proteins with the ultimate aim of helping patients who have a brain injury or a neurodegenerative disease. It is important to note that the partnership between UTAS and Bestenbalt LLC is a critical step in the development of these exciting research discoveries into commercially viable outcomes for the Australian Biotechnology Industry and the broader Australian community.Read moreRead less
Proteomic analysis of central nervous system inflammation in multiple sclerosis. This project aims to identify new therapeutic targets and diagnostics for Multiple Sclerosis (MS) the most common neurological disease in young adults. The estimated economic burden of this disease in Australia is around $2 billion per annum. There is also a large social cost to take into account. In spite of a great deal of research, current therapies are limited. We expect that this this research will: lead to n ....Proteomic analysis of central nervous system inflammation in multiple sclerosis. This project aims to identify new therapeutic targets and diagnostics for Multiple Sclerosis (MS) the most common neurological disease in young adults. The estimated economic burden of this disease in Australia is around $2 billion per annum. There is also a large social cost to take into account. In spite of a great deal of research, current therapies are limited. We expect that this this research will: lead to new therapies and better diagnostics, which will reduce the financial and human cost of this disease; generate IP with subsequent economic benefits and; expand proteomics technologies which will have flow on effects including economic benefits and benefits to a wide range of basic research. Read moreRead less
Rapid Development of Biocompatible Stent Grafts for Aortic Aneurysms. Weakening of the aorta may cause an aneurysm. The present technique of its treatment involves replacing the weakened portion of the aorta with a synthetic graft. Failure of this treatment often occurs due to non-compatibility of the stent graft with natural aorta. One possible reason for this is a mismatch between elastic natural aorta and the non-elastic artificial graft. The core component of our project is the selection and ....Rapid Development of Biocompatible Stent Grafts for Aortic Aneurysms. Weakening of the aorta may cause an aneurysm. The present technique of its treatment involves replacing the weakened portion of the aorta with a synthetic graft. Failure of this treatment often occurs due to non-compatibility of the stent graft with natural aorta. One possible reason for this is a mismatch between elastic natural aorta and the non-elastic artificial graft. The core component of our project is the selection and development of a suitable biomaterial and optimization of the stent design based on hemodynamics flow analysis and its fabrication with the Fused Deposition Modelling (FDM) process.Read moreRead less
In Vitro Study of Hemodynamic Stresses and Endothelialization of Artificial Coronary Arteries. Restenosis (recurrence of the disease) is a major problem in the case of patients undergoing artificial artery by-pass surgery. Ideally the design for manufacturing the scaffold for cell adhesion of the artery should factor in hemodynamic forces and optimised geometry to withstand the hemodynamic stresses and other forces. This project aims to investigate the material for manufacturing the artificial a ....In Vitro Study of Hemodynamic Stresses and Endothelialization of Artificial Coronary Arteries. Restenosis (recurrence of the disease) is a major problem in the case of patients undergoing artificial artery by-pass surgery. Ideally the design for manufacturing the scaffold for cell adhesion of the artery should factor in hemodynamic forces and optimised geometry to withstand the hemodynamic stresses and other forces. This project aims to investigate the material for manufacturing the artificial artery using Fused Deposition Modeling and to develop methods for the establishment of endothelium on the artificial artery, concluding a restenosis-free solution for by-pass surgery. The knowledge gained through this work would be applicable to the design of other prosthetic devices.Read moreRead less
Computer simulation techniques to reduce the incidence of femoral fracture after hip replacement surgery. Australia's ageing population is driving an increase of 5% to 10% a year in the number of primary total hip replacements. We will move beyond conventional surgical techniques, to deliver the science for an accurate, reliable computer-based system that is significantly more accurate and reliable. Optimising implant selection criteria to better match patients' activity levels and bone physiolo ....Computer simulation techniques to reduce the incidence of femoral fracture after hip replacement surgery. Australia's ageing population is driving an increase of 5% to 10% a year in the number of primary total hip replacements. We will move beyond conventional surgical techniques, to deliver the science for an accurate, reliable computer-based system that is significantly more accurate and reliable. Optimising implant selection criteria to better match patients' activity levels and bone physiology and minimise revision rates; this has major implications for the national health budget and patients' quality of life. Our advances will allow the implementation of improved surgical techniques that minimise the risk of implant related bone failure.Read moreRead less
New modulators of voltage-gated sodium channel subtypes from Australian Tarantula venoms. The venoms of Australian tarantula spiders provide a unique and untapped source of bioactive molecules. From a large stock of venom, and in collaboration with Australian pharmaceutical company Xenome, we will develop a comprehensive library of venom components suitable for drug screening. Potential national benefits from this work include a huge reduction in the healthcare bill deriving from a new treatmen ....New modulators of voltage-gated sodium channel subtypes from Australian Tarantula venoms. The venoms of Australian tarantula spiders provide a unique and untapped source of bioactive molecules. From a large stock of venom, and in collaboration with Australian pharmaceutical company Xenome, we will develop a comprehensive library of venom components suitable for drug screening. Potential national benefits from this work include a huge reduction in the healthcare bill deriving from a new treatment for pain, as well as substantial royalty returns from drugs sales. Discoveries from the program are also likely to lead to an enhancement in Australia's reputation in the neurosciences and to the development of new diagnostic research tools. The major community benefit will be a reduction in the suffering of chronic pain patients.Read moreRead less